AbbVie vs Morgan Stanley: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Morgan Stanley was founded in 1935 by Henry S. Morgan, Harold Stanley and is led by Ted Pick.
Company facts
AbbVie
- Founded
- 2013
- Headquarters
- North Chicago, Illinois
- Current CEO
- Robert A. Michael
- Employees
- 57,000
Morgan Stanley
- Founded
- 1935
- Headquarters
- New York, New York, United States
- Current CEO
- Ted Pick
- Employees
- 83,000
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Morgan Stanley
Henry S. Morgan
Henry S. Morgan co-founded Morgan Stanley in 1935 after the Glass-Steagall Act required J.P. Morgan & Co. to separate its securities business from commercial banking.
Harold Stanley
Harold Stanley (1885-1963) co-founded Morgan Stanley in 1935 alongside Henry S. Morgan. Following the passage of the Glass-Steagall Act, which forced banks to separate commercial and investment banking, Stanley left J.P. Morgan & Co.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Morgan Stanley
- James Gorman2010–2023
Former Chairman and Chief Executive Officer
Gorman's tenure moved Morgan Stanley toward recurring fee revenue. He became executive chairman after stepping down as CEO and left the board at the end of 2024.
Source - Ted Pick2024–present
Chairman and Chief Executive Officer
Under Pick, Morgan Stanley reported record 2025 net revenues of $70.6B and record Q2 2026 results.
Source
Timeline: AbbVie and Morgan Stanley side by side
1935Morgan Stanley
Morgan Stanley Founded
Henry S. Morgan and Harold Stanley officially launch the top investment bank following the historic Glass-Steagall split.
1996Morgan Stanley
Acquired Van Kampen American Capital
Morgan Stanley acquired Van Kampen American Capital in 1996.
1997Morgan Stanley
Merged with Dean Witter Discover & Co
Morgan Stanley merged with Dean Witter Discover & Co in February 1997.
2008Morgan Stanley
Bank Holding Company Conversion
Facing total catastrophic collapse, the firm converts into a traditional bank holding company to survive the global financial crisis.
2009Morgan Stanley
The Smith Barney Acquisition
then-CEO James Gorman masterminds the acquisition of Smith Barney, instantly creating a dominant retail wealth management leader.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2018Morgan Stanley
Acquired Mesa West
Morgan Stanley acquired Mesa West in March 2018.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2020Morgan Stanley
E*TRADE Acquisition
Morgan Stanley dominates the self-directed brokerage market by acquiring E*TRADE for $13 billion.
2021Morgan Stanley
Acquired Eaton Vance
Morgan Stanley acquired Eaton Vance for $7 billion. Morgan Stanley acquired Eaton Vance for about $7B, completed in March 2021, adding Parametric, Calvert, and Atlanta Capital.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024Morgan Stanley
Ted Pick Appointed CEO
Following a competitive internal succession, Ted Pick takes the helm to heavily drive the integration strategy.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Morgan Stanley
- Eaton Vance2021$7B
- E*TRADE2020$13B
- Smith Barney2009Undisclosed
Questions about AbbVie vs Morgan Stanley
Who is the CEO of AbbVie Inc. and Morgan Stanley?
AbbVie Inc. is led by Robert A. Michael and Morgan Stanley is led by Ted Pick. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Morgan Stanley?
Morgan Stanley was founded in 1935 — 78 years before AbbVie Inc., which was founded in 2013. Morgan Stanley's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Morgan Stanley?
AbbVie Inc. employs approximately 57,000 people, while Morgan Stanley employs approximately 83,000. Morgan Stanley has the larger workforce at 83,000 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Morgan Stanley headquartered?
Both AbbVie Inc. and Morgan Stanley are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Morgan Stanley?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Morgan Stanley was founded by Henry S. Morgan, Harold Stanley.
Which company has a longer operating history — AbbVie Inc. or Morgan Stanley?
Morgan Stanley has been operating for approximately 91 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Morgan Stanley overview